nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—Anxiety depression—Temozolomide—malignant glioma	0.0393	0.0659	CcSEcCtD
Zoledronate—GGPS1—brainstem—malignant glioma	0.0275	0.0743	CbGeAlD
Zoledronate—GGPS1—retina—malignant glioma	0.0266	0.0717	CbGeAlD
Zoledronate—GGPS1—telencephalon—malignant glioma	0.0244	0.066	CbGeAlD
Zoledronate—Leg edema—Temozolomide—malignant glioma	0.024	0.0402	CcSEcCtD
Zoledronate—GGPS1—medulla oblongata—malignant glioma	0.0192	0.0518	CbGeAlD
Zoledronate—GGPS1—midbrain—malignant glioma	0.0176	0.0474	CbGeAlD
Zoledronate—GGPS1—spinal cord—malignant glioma	0.0171	0.0462	CbGeAlD
Zoledronate—CA14—telencephalon—malignant glioma	0.0146	0.0394	CbGeAlD
Zoledronate—GGPS1—central nervous system—malignant glioma	0.0139	0.0375	CbGeAlD
Zoledronate—GGPS1—cerebellum—malignant glioma	0.0136	0.0366	CbGeAlD
Zoledronate—Azotaemia—Carmustine—malignant glioma	0.0125	0.021	CcSEcCtD
Zoledronate—Nephropathy toxic—Carmustine—malignant glioma	0.0116	0.0195	CcSEcCtD
Zoledronate—CA14—medulla oblongata—malignant glioma	0.0115	0.031	CbGeAlD
Zoledronate—CA12—telencephalon—malignant glioma	0.0114	0.0307	CbGeAlD
Zoledronate—FDPS—telencephalon—malignant glioma	0.0113	0.0304	CbGeAlD
Zoledronate—GGPS1—brain—malignant glioma	0.011	0.0298	CbGeAlD
Zoledronate—CA14—midbrain—malignant glioma	0.0105	0.0283	CbGeAlD
Zoledronate—CA14—spinal cord—malignant glioma	0.0102	0.0276	CbGeAlD
Zoledronate—Interstitial lung disease—Carmustine—malignant glioma	0.00944	0.0158	CcSEcCtD
Zoledronate—Interstitial lung disease—Temozolomide—malignant glioma	0.00912	0.0153	CcSEcCtD
Zoledronate—Influenza-like symptoms—Temozolomide—malignant glioma	0.00904	0.0151	CcSEcCtD
Zoledronate—FDPS—medulla oblongata—malignant glioma	0.00885	0.0239	CbGeAlD
Zoledronate—Coagulopathy—Temozolomide—malignant glioma	0.00829	0.0139	CcSEcCtD
Zoledronate—Hyperaesthesia—Temozolomide—malignant glioma	0.00822	0.0138	CcSEcCtD
Zoledronate—CA14—cerebellum—malignant glioma	0.00812	0.0219	CbGeAlD
Zoledronate—FDPS—midbrain—malignant glioma	0.00809	0.0218	CbGeAlD
Zoledronate—Rigors—Temozolomide—malignant glioma	0.00791	0.0133	CcSEcCtD
Zoledronate—FDPS—spinal cord—malignant glioma	0.00789	0.0213	CbGeAlD
Zoledronate—CA2—embryo—malignant glioma	0.00719	0.0194	CbGeAlD
Zoledronate—Neck pain—Carmustine—malignant glioma	0.00676	0.0113	CcSEcCtD
Zoledronate—Injection site reaction—Carmustine—malignant glioma	0.00664	0.0111	CcSEcCtD
Zoledronate—CA14—brain—malignant glioma	0.00659	0.0178	CbGeAlD
Zoledronate—CA2—brainstem—malignant glioma	0.00659	0.0178	CbGeAlD
Zoledronate—ABCC1—telencephalon—malignant glioma	0.00654	0.0177	CbGeAlD
Zoledronate—Musculoskeletal pain—Temozolomide—malignant glioma	0.00653	0.0109	CcSEcCtD
Zoledronate—CA12—central nervous system—malignant glioma	0.00648	0.0175	CbGeAlD
Zoledronate—FDPS—central nervous system—malignant glioma	0.0064	0.0173	CbGeAlD
Zoledronate—Candida infection—Carmustine—malignant glioma	0.00638	0.0107	CcSEcCtD
Zoledronate—CA2—retina—malignant glioma	0.00636	0.0172	CbGeAlD
Zoledronate—Influenza like illness—Temozolomide—malignant glioma	0.00627	0.0105	CcSEcCtD
Zoledronate—FDPS—cerebellum—malignant glioma	0.00626	0.0169	CbGeAlD
Zoledronate—Candida infection—Temozolomide—malignant glioma	0.00616	0.0103	CcSEcCtD
Zoledronate—Neoplasm—Carmustine—malignant glioma	0.00604	0.0101	CcSEcCtD
Zoledronate—CA2—telencephalon—malignant glioma	0.00585	0.0158	CbGeAlD
Zoledronate—Neoplasm—Temozolomide—malignant glioma	0.00584	0.00978	CcSEcCtD
Zoledronate—Swelling—Carmustine—malignant glioma	0.0055	0.00921	CcSEcCtD
Zoledronate—Eye pain—Carmustine—malignant glioma	0.00537	0.009	CcSEcCtD
Zoledronate—Eye pain—Temozolomide—malignant glioma	0.00519	0.0087	CcSEcCtD
Zoledronate—CA12—brain—malignant glioma	0.00514	0.0139	CbGeAlD
Zoledronate—FDPS—brain—malignant glioma	0.00508	0.0137	CbGeAlD
Zoledronate—Risedronate—PTGS2—malignant glioma	0.005	0.529	CrCbGaD
Zoledronate—Thirst—Temozolomide—malignant glioma	0.00492	0.00825	CcSEcCtD
Zoledronate—CA2—medulla oblongata—malignant glioma	0.0046	0.0124	CbGeAlD
Zoledronate—Clodronate—PTGS2—malignant glioma	0.00446	0.471	CrCbGaD
Zoledronate—Hypokalaemia—Carmustine—malignant glioma	0.00441	0.0074	CcSEcCtD
Zoledronate—Dehydration—Temozolomide—malignant glioma	0.00436	0.0073	CcSEcCtD
Zoledronate—Muscular weakness—Carmustine—malignant glioma	0.00428	0.00717	CcSEcCtD
Zoledronate—Hypokalaemia—Temozolomide—malignant glioma	0.00426	0.00715	CcSEcCtD
Zoledronate—CA2—midbrain—malignant glioma	0.0042	0.0113	CbGeAlD
Zoledronate—Dysphagia—Carmustine—malignant glioma	0.00419	0.00702	CcSEcCtD
Zoledronate—Muscular weakness—Temozolomide—malignant glioma	0.00413	0.00693	CcSEcCtD
Zoledronate—CA2—spinal cord—malignant glioma	0.0041	0.0111	CbGeAlD
Zoledronate—Abdominal distension—Temozolomide—malignant glioma	0.00408	0.00683	CcSEcCtD
Zoledronate—Dysphagia—Temozolomide—malignant glioma	0.00405	0.00679	CcSEcCtD
Zoledronate—Pancytopenia—Carmustine—malignant glioma	0.00398	0.00667	CcSEcCtD
Zoledronate—Sweating increased—Temozolomide—malignant glioma	0.00394	0.00661	CcSEcCtD
Zoledronate—Neutropenia—Carmustine—malignant glioma	0.00392	0.00657	CcSEcCtD
Zoledronate—Pancytopenia—Temozolomide—malignant glioma	0.00385	0.00645	CcSEcCtD
Zoledronate—Neutropenia—Temozolomide—malignant glioma	0.00379	0.00635	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00376	0.00631	CcSEcCtD
Zoledronate—Pollakiuria—Temozolomide—malignant glioma	0.00374	0.00627	CcSEcCtD
Zoledronate—Depression—Carmustine—malignant glioma	0.00373	0.00624	CcSEcCtD
Zoledronate—Weight increased—Temozolomide—malignant glioma	0.00369	0.00618	CcSEcCtD
Zoledronate—Renal failure—Carmustine—malignant glioma	0.00367	0.00616	CcSEcCtD
Zoledronate—Weight decreased—Temozolomide—malignant glioma	0.00366	0.00614	CcSEcCtD
Zoledronate—Stomatitis—Carmustine—malignant glioma	0.00364	0.0061	CcSEcCtD
Zoledronate—ABCC1—cerebellum—malignant glioma	0.00364	0.00981	CbGeAlD
Zoledronate—Urinary tract infection—Carmustine—malignant glioma	0.00363	0.00609	CcSEcCtD
Zoledronate—Infestation NOS—Temozolomide—malignant glioma	0.00361	0.00605	CcSEcCtD
Zoledronate—Infestation—Temozolomide—malignant glioma	0.00361	0.00605	CcSEcCtD
Zoledronate—Depression—Temozolomide—malignant glioma	0.0036	0.00603	CcSEcCtD
Zoledronate—Stomatitis—Temozolomide—malignant glioma	0.00352	0.0059	CcSEcCtD
Zoledronate—Urinary tract infection—Temozolomide—malignant glioma	0.00351	0.00588	CcSEcCtD
Zoledronate—Hypoaesthesia—Carmustine—malignant glioma	0.00334	0.00559	CcSEcCtD
Zoledronate—CA2—central nervous system—malignant glioma	0.00332	0.00897	CbGeAlD
Zoledronate—Oedema peripheral—Carmustine—malignant glioma	0.0033	0.00554	CcSEcCtD
Zoledronate—Connective tissue disorder—Carmustine—malignant glioma	0.0033	0.00552	CcSEcCtD
Zoledronate—CA2—cerebellum—malignant glioma	0.00325	0.00877	CbGeAlD
Zoledronate—Hypoaesthesia—Temozolomide—malignant glioma	0.00323	0.00541	CcSEcCtD
Zoledronate—Urinary tract disorder—Temozolomide—malignant glioma	0.0032	0.00537	CcSEcCtD
Zoledronate—Oedema peripheral—Temozolomide—malignant glioma	0.00319	0.00535	CcSEcCtD
Zoledronate—Connective tissue disorder—Temozolomide—malignant glioma	0.00319	0.00534	CcSEcCtD
Zoledronate—Urethral disorder—Temozolomide—malignant glioma	0.00318	0.00533	CcSEcCtD
Zoledronate—Eye disorder—Carmustine—malignant glioma	0.00313	0.00525	CcSEcCtD
Zoledronate—Flushing—Carmustine—malignant glioma	0.00311	0.00522	CcSEcCtD
Zoledronate—Eye disorder—Temozolomide—malignant glioma	0.00303	0.00508	CcSEcCtD
Zoledronate—Cardiac disorder—Temozolomide—malignant glioma	0.00301	0.00504	CcSEcCtD
Zoledronate—Flushing—Temozolomide—malignant glioma	0.00301	0.00504	CcSEcCtD
Zoledronate—Arrhythmia—Carmustine—malignant glioma	0.003	0.00502	CcSEcCtD
Zoledronate—Alopecia—Carmustine—malignant glioma	0.00296	0.00497	CcSEcCtD
Zoledronate—ABCC1—brain—malignant glioma	0.00295	0.00797	CbGeAlD
Zoledronate—Angiopathy—Temozolomide—malignant glioma	0.00294	0.00493	CcSEcCtD
Zoledronate—Mental disorder—Carmustine—malignant glioma	0.00294	0.00493	CcSEcCtD
Zoledronate—Immune system disorder—Temozolomide—malignant glioma	0.00293	0.00491	CcSEcCtD
Zoledronate—Mediastinal disorder—Temozolomide—malignant glioma	0.00292	0.0049	CcSEcCtD
Zoledronate—Erythema—Carmustine—malignant glioma	0.00292	0.00489	CcSEcCtD
Zoledronate—Malnutrition—Carmustine—malignant glioma	0.00292	0.00489	CcSEcCtD
Zoledronate—Chills—Temozolomide—malignant glioma	0.00291	0.00487	CcSEcCtD
Zoledronate—Alopecia—Temozolomide—malignant glioma	0.00286	0.0048	CcSEcCtD
Zoledronate—Mental disorder—Temozolomide—malignant glioma	0.00284	0.00476	CcSEcCtD
Zoledronate—Back pain—Carmustine—malignant glioma	0.00282	0.00473	CcSEcCtD
Zoledronate—Erythema—Temozolomide—malignant glioma	0.00282	0.00473	CcSEcCtD
Zoledronate—Malnutrition—Temozolomide—malignant glioma	0.00282	0.00473	CcSEcCtD
Zoledronate—Dysgeusia—Temozolomide—malignant glioma	0.00276	0.00463	CcSEcCtD
Zoledronate—Vision blurred—Carmustine—malignant glioma	0.00275	0.00461	CcSEcCtD
Zoledronate—Tremor—Carmustine—malignant glioma	0.00274	0.00459	CcSEcCtD
Zoledronate—Back pain—Temozolomide—malignant glioma	0.00273	0.00457	CcSEcCtD
Zoledronate—Anaemia—Carmustine—malignant glioma	0.0027	0.00452	CcSEcCtD
Zoledronate—Agitation—Carmustine—malignant glioma	0.00268	0.0045	CcSEcCtD
Zoledronate—Vision blurred—Temozolomide—malignant glioma	0.00266	0.00446	CcSEcCtD
Zoledronate—Tremor—Temozolomide—malignant glioma	0.00264	0.00443	CcSEcCtD
Zoledronate—CA2—brain—malignant glioma	0.00264	0.00712	CbGeAlD
Zoledronate—Ill-defined disorder—Temozolomide—malignant glioma	0.00262	0.00439	CcSEcCtD
Zoledronate—Leukopenia—Carmustine—malignant glioma	0.00261	0.00438	CcSEcCtD
Zoledronate—Anaemia—Temozolomide—malignant glioma	0.00261	0.00437	CcSEcCtD
Zoledronate—Agitation—Temozolomide—malignant glioma	0.00259	0.00435	CcSEcCtD
Zoledronate—Angioedema—Temozolomide—malignant glioma	0.00258	0.00432	CcSEcCtD
Zoledronate—Malaise—Temozolomide—malignant glioma	0.00254	0.00426	CcSEcCtD
Zoledronate—Vertigo—Temozolomide—malignant glioma	0.00254	0.00425	CcSEcCtD
Zoledronate—Convulsion—Carmustine—malignant glioma	0.00253	0.00424	CcSEcCtD
Zoledronate—Leukopenia—Temozolomide—malignant glioma	0.00253	0.00423	CcSEcCtD
Zoledronate—Hypertension—Carmustine—malignant glioma	0.00252	0.00423	CcSEcCtD
Zoledronate—Palpitations—Temozolomide—malignant glioma	0.00249	0.00418	CcSEcCtD
Zoledronate—Chest pain—Carmustine—malignant glioma	0.00249	0.00417	CcSEcCtD
Zoledronate—Myalgia—Carmustine—malignant glioma	0.00249	0.00417	CcSEcCtD
Zoledronate—Anxiety—Carmustine—malignant glioma	0.00248	0.00415	CcSEcCtD
Zoledronate—Cough—Temozolomide—malignant glioma	0.00246	0.00413	CcSEcCtD
Zoledronate—Convulsion—Temozolomide—malignant glioma	0.00244	0.0041	CcSEcCtD
Zoledronate—Hypertension—Temozolomide—malignant glioma	0.00244	0.00408	CcSEcCtD
Zoledronate—Confusional state—Carmustine—malignant glioma	0.0024	0.00403	CcSEcCtD
Zoledronate—Arthralgia—Temozolomide—malignant glioma	0.0024	0.00403	CcSEcCtD
Zoledronate—Myalgia—Temozolomide—malignant glioma	0.0024	0.00403	CcSEcCtD
Zoledronate—Anxiety—Temozolomide—malignant glioma	0.00239	0.00401	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00239	0.004	CcSEcCtD
Zoledronate—Oedema—Carmustine—malignant glioma	0.00238	0.00399	CcSEcCtD
Zoledronate—Discomfort—Temozolomide—malignant glioma	0.00237	0.00398	CcSEcCtD
Zoledronate—Infection—Carmustine—malignant glioma	0.00237	0.00397	CcSEcCtD
Zoledronate—Dry mouth—Temozolomide—malignant glioma	0.00235	0.00394	CcSEcCtD
Zoledronate—Thrombocytopenia—Carmustine—malignant glioma	0.00233	0.00391	CcSEcCtD
Zoledronate—Tachycardia—Carmustine—malignant glioma	0.00233	0.0039	CcSEcCtD
Zoledronate—Confusional state—Temozolomide—malignant glioma	0.00232	0.00389	CcSEcCtD
Zoledronate—Anaphylactic shock—Temozolomide—malignant glioma	0.0023	0.00386	CcSEcCtD
Zoledronate—Oedema—Temozolomide—malignant glioma	0.0023	0.00386	CcSEcCtD
Zoledronate—Infection—Temozolomide—malignant glioma	0.00229	0.00383	CcSEcCtD
Zoledronate—Anorexia—Carmustine—malignant glioma	0.00227	0.00381	CcSEcCtD
Zoledronate—Nervous system disorder—Temozolomide—malignant glioma	0.00226	0.00379	CcSEcCtD
Zoledronate—Thrombocytopenia—Temozolomide—malignant glioma	0.00225	0.00378	CcSEcCtD
Zoledronate—Skin disorder—Temozolomide—malignant glioma	0.00224	0.00375	CcSEcCtD
Zoledronate—Hypotension—Carmustine—malignant glioma	0.00223	0.00373	CcSEcCtD
Zoledronate—Hyperhidrosis—Temozolomide—malignant glioma	0.00223	0.00373	CcSEcCtD
Zoledronate—Anorexia—Temozolomide—malignant glioma	0.0022	0.00368	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00217	0.00364	CcSEcCtD
Zoledronate—Insomnia—Carmustine—malignant glioma	0.00216	0.00361	CcSEcCtD
Zoledronate—Paraesthesia—Carmustine—malignant glioma	0.00214	0.00359	CcSEcCtD
Zoledronate—Dyspnoea—Carmustine—malignant glioma	0.00212	0.00356	CcSEcCtD
Zoledronate—Somnolence—Carmustine—malignant glioma	0.00212	0.00355	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0021	0.00352	CcSEcCtD
Zoledronate—Insomnia—Temozolomide—malignant glioma	0.00208	0.00349	CcSEcCtD
Zoledronate—Decreased appetite—Carmustine—malignant glioma	0.00207	0.00347	CcSEcCtD
Zoledronate—Paraesthesia—Temozolomide—malignant glioma	0.00207	0.00347	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Carmustine—malignant glioma	0.00206	0.00345	CcSEcCtD
Zoledronate—Dyspnoea—Temozolomide—malignant glioma	0.00205	0.00344	CcSEcCtD
Zoledronate—Somnolence—Temozolomide—malignant glioma	0.00205	0.00343	CcSEcCtD
Zoledronate—Constipation—Carmustine—malignant glioma	0.00204	0.00342	CcSEcCtD
Zoledronate—Pain—Carmustine—malignant glioma	0.00204	0.00342	CcSEcCtD
Zoledronate—Dyspepsia—Temozolomide—malignant glioma	0.00203	0.0034	CcSEcCtD
Zoledronate—Decreased appetite—Temozolomide—malignant glioma	0.002	0.00336	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00199	0.00333	CcSEcCtD
Zoledronate—Fatigue—Temozolomide—malignant glioma	0.00199	0.00333	CcSEcCtD
Zoledronate—Pain—Temozolomide—malignant glioma	0.00197	0.0033	CcSEcCtD
Zoledronate—Constipation—Temozolomide—malignant glioma	0.00197	0.0033	CcSEcCtD
Zoledronate—Feeling abnormal—Carmustine—malignant glioma	0.00196	0.00329	CcSEcCtD
Zoledronate—Gastrointestinal pain—Carmustine—malignant glioma	0.00195	0.00327	CcSEcCtD
Zoledronate—Feeling abnormal—Temozolomide—malignant glioma	0.0019	0.00318	CcSEcCtD
Zoledronate—Abdominal pain—Carmustine—malignant glioma	0.00188	0.00316	CcSEcCtD
Zoledronate—Body temperature increased—Carmustine—malignant glioma	0.00188	0.00316	CcSEcCtD
Zoledronate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00188	0.00316	CcSEcCtD
Zoledronate—Urticaria—Temozolomide—malignant glioma	0.00183	0.00307	CcSEcCtD
Zoledronate—Abdominal pain—Temozolomide—malignant glioma	0.00182	0.00305	CcSEcCtD
Zoledronate—Body temperature increased—Temozolomide—malignant glioma	0.00182	0.00305	CcSEcCtD
Zoledronate—Hypersensitivity—Carmustine—malignant glioma	0.00176	0.00294	CcSEcCtD
Zoledronate—Asthenia—Carmustine—malignant glioma	0.00171	0.00287	CcSEcCtD
Zoledronate—Hypersensitivity—Temozolomide—malignant glioma	0.0017	0.00284	CcSEcCtD
Zoledronate—Asthenia—Temozolomide—malignant glioma	0.00165	0.00277	CcSEcCtD
Zoledronate—Diarrhoea—Carmustine—malignant glioma	0.00163	0.00273	CcSEcCtD
Zoledronate—Pruritus—Temozolomide—malignant glioma	0.00163	0.00273	CcSEcCtD
Zoledronate—Dizziness—Carmustine—malignant glioma	0.00158	0.00264	CcSEcCtD
Zoledronate—Diarrhoea—Temozolomide—malignant glioma	0.00158	0.00264	CcSEcCtD
Zoledronate—Dizziness—Temozolomide—malignant glioma	0.00152	0.00255	CcSEcCtD
Zoledronate—Vomiting—Carmustine—malignant glioma	0.00152	0.00254	CcSEcCtD
Zoledronate—Rash—Carmustine—malignant glioma	0.0015	0.00252	CcSEcCtD
Zoledronate—Dermatitis—Carmustine—malignant glioma	0.0015	0.00252	CcSEcCtD
Zoledronate—Headache—Carmustine—malignant glioma	0.00149	0.0025	CcSEcCtD
Zoledronate—Vomiting—Temozolomide—malignant glioma	0.00146	0.00245	CcSEcCtD
Zoledronate—Rash—Temozolomide—malignant glioma	0.00145	0.00243	CcSEcCtD
Zoledronate—Dermatitis—Temozolomide—malignant glioma	0.00145	0.00243	CcSEcCtD
Zoledronate—Headache—Temozolomide—malignant glioma	0.00144	0.00242	CcSEcCtD
Zoledronate—Nausea—Carmustine—malignant glioma	0.00142	0.00237	CcSEcCtD
Zoledronate—Nausea—Temozolomide—malignant glioma	0.00137	0.00229	CcSEcCtD
Zoledronate—GGPS1—Metabolism—RTEL1—malignant glioma	0.000644	0.0276	CbGpPWpGaD
Zoledronate—ABCC1—Irinotecan Pathway—APC—malignant glioma	0.000493	0.0211	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000461	0.0197	CbGpPWpGaD
Zoledronate—ABCC1—S1P1 pathway—PDGFB—malignant glioma	0.000447	0.0191	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000446	0.0191	CbGpPWpGaD
Zoledronate—ABCC1—S1P1 pathway—KDR—malignant glioma	0.000419	0.0179	CbGpPWpGaD
Zoledronate—FDPS—SREBP signalling—PPARG—malignant glioma	0.000372	0.0159	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—COX8A—malignant glioma	0.00037	0.0158	CbGpPWpGaD
Zoledronate—ABCC1—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000353	0.0151	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000331	0.0142	CbGpPWpGaD
Zoledronate—CA14—Metabolism—RTEL1—malignant glioma	0.000315	0.0135	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ASMT—malignant glioma	0.000315	0.0135	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000308	0.0132	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—BCAN—malignant glioma	0.000296	0.0127	CbGpPWpGaD
Zoledronate—ABCC1—S1P1 pathway—PTGS2—malignant glioma	0.000293	0.0125	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—RTEL1—malignant glioma	0.000275	0.0118	CbGpPWpGaD
Zoledronate—CA12—Metabolism—RTEL1—malignant glioma	0.000265	0.0114	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—IDH2—malignant glioma	0.000238	0.0102	CbGpPWpGaD
Zoledronate—ABCC1—S1P1 pathway—VEGFA—malignant glioma	0.000231	0.00988	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000225	0.00963	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP2B6—malignant glioma	0.000224	0.0096	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—IDH1—malignant glioma	0.000205	0.00878	CbGpPWpGaD
Zoledronate—CA2—Metabolism—RTEL1—malignant glioma	0.000203	0.00868	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—SPHK1—malignant glioma	0.000198	0.0085	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000197	0.00842	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP2C18—malignant glioma	0.000194	0.00832	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00019	0.00814	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000183	0.00785	CbGpPWpGaD
Zoledronate—CA14—Metabolism—COX8A—malignant glioma	0.000181	0.00774	CbGpPWpGaD
Zoledronate—FDPS—SREBP signalling—PIK3CA—malignant glioma	0.00018	0.00771	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000167	0.00715	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000161	0.0069	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—COX8A—malignant glioma	0.000158	0.00676	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GSTT1—malignant glioma	0.000157	0.00673	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ASMT—malignant glioma	0.000154	0.00658	CbGpPWpGaD
Zoledronate—CA12—Metabolism—COX8A—malignant glioma	0.000152	0.00652	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTGS1—malignant glioma	0.000147	0.00631	CbGpPWpGaD
Zoledronate—FDPS—SREBP signalling—AKT1—malignant glioma	0.000147	0.0063	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000147	0.00629	CbGpPWpGaD
Zoledronate—CA14—Metabolism—BCAN—malignant glioma	0.000144	0.00619	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000141	0.00605	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—BCHE—malignant glioma	0.000137	0.00586	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—SLC5A5—malignant glioma	0.000135	0.00579	CbGpPWpGaD
Zoledronate—ABCC1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000135	0.00579	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ASMT—malignant glioma	0.000134	0.00575	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000131	0.00562	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ASMT—malignant glioma	0.00013	0.00555	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000128	0.00548	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000127	0.00543	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—BCAN—malignant glioma	0.000126	0.00541	CbGpPWpGaD
Zoledronate—CA12—Metabolism—BCAN—malignant glioma	0.000122	0.00521	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00012	0.00515	CbGpPWpGaD
Zoledronate—CA2—Metabolism—COX8A—malignant glioma	0.000116	0.00499	CbGpPWpGaD
Zoledronate—CA14—Metabolism—IDH2—malignant glioma	0.000116	0.00499	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000111	0.00473	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00011	0.00471	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP2B6—malignant glioma	0.00011	0.00469	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GSTP1—malignant glioma	0.000109	0.00467	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CAT—malignant glioma	0.000106	0.00454	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—IDH2—malignant glioma	0.000102	0.00436	CbGpPWpGaD
Zoledronate—CA14—Metabolism—IDH1—malignant glioma	0.0001	0.00429	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—NCOR1—malignant glioma	0.0001	0.00429	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ASMT—malignant glioma	9.9e-05	0.00424	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—RTEL1—malignant glioma	9.82e-05	0.0042	CbGpPWpGaD
Zoledronate—CA12—Metabolism—IDH2—malignant glioma	9.82e-05	0.0042	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SPHK1—malignant glioma	9.69e-05	0.00415	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	9.62e-05	0.00412	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.6e-05	0.00411	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP2B6—malignant glioma	9.57e-05	0.0041	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP2C18—malignant glioma	9.49e-05	0.00407	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—APOD—malignant glioma	9.36e-05	0.00401	CbGpPWpGaD
Zoledronate—CA2—Metabolism—BCAN—malignant glioma	9.31e-05	0.00399	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP2B6—malignant glioma	9.23e-05	0.00395	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—IDH1—malignant glioma	8.75e-05	0.00375	CbGpPWpGaD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—malignant glioma	8.68e-05	0.00372	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SPHK1—malignant glioma	8.47e-05	0.00363	CbGpPWpGaD
Zoledronate—CA12—Metabolism—IDH1—malignant glioma	8.44e-05	0.00361	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP2C18—malignant glioma	8.3e-05	0.00355	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SPHK1—malignant glioma	8.17e-05	0.0035	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CAV1—malignant glioma	8.16e-05	0.0035	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP2C18—malignant glioma	8e-05	0.00343	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.83e-05	0.00335	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.8e-05	0.00334	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTT1—malignant glioma	7.68e-05	0.00329	CbGpPWpGaD
Zoledronate—CA2—Metabolism—IDH2—malignant glioma	7.51e-05	0.00321	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CG—malignant glioma	7.44e-05	0.00318	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS1—malignant glioma	7.2e-05	0.00308	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PPARG—malignant glioma	7.18e-05	0.00307	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.13e-05	0.00305	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP2B6—malignant glioma	7.06e-05	0.00302	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.02e-05	0.003	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.88e-05	0.00295	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.79e-05	0.00291	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTT1—malignant glioma	6.71e-05	0.00287	CbGpPWpGaD
Zoledronate—CA14—Metabolism—BCHE—malignant glioma	6.69e-05	0.00286	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SLC5A5—malignant glioma	6.61e-05	0.00283	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CD—malignant glioma	6.54e-05	0.0028	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTT1—malignant glioma	6.47e-05	0.00277	CbGpPWpGaD
Zoledronate—CA2—Metabolism—IDH1—malignant glioma	6.45e-05	0.00276	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS1—malignant glioma	6.29e-05	0.00269	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.27e-05	0.00268	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SPHK1—malignant glioma	6.25e-05	0.00267	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP2C18—malignant glioma	6.12e-05	0.00262	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS1—malignant glioma	6.06e-05	0.0026	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—BCHE—malignant glioma	5.85e-05	0.0025	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SLC5A5—malignant glioma	5.78e-05	0.00247	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CB—malignant glioma	5.7e-05	0.00244	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTGS2—malignant glioma	5.65e-05	0.00242	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—COX8A—malignant glioma	5.64e-05	0.00241	CbGpPWpGaD
Zoledronate—CA12—Metabolism—BCHE—malignant glioma	5.64e-05	0.00241	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SLC5A5—malignant glioma	5.57e-05	0.00238	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.46e-05	0.00234	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.41e-05	0.00232	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BCAN—malignant glioma	5.38e-05	0.0023	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTP1—malignant glioma	5.32e-05	0.00228	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CAT—malignant glioma	5.18e-05	0.00222	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.04e-05	0.00216	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTT1—malignant glioma	4.95e-05	0.00212	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTEN—malignant glioma	4.92e-05	0.00211	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NCOR1—malignant glioma	4.89e-05	0.00209	CbGpPWpGaD
Zoledronate—ABCC1—Disease—DTX1—malignant glioma	4.87e-05	0.00208	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ASMT—malignant glioma	4.79e-05	0.00205	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—TFRC—malignant glioma	4.79e-05	0.00205	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.72e-05	0.00202	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.69e-05	0.00201	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTP1—malignant glioma	4.65e-05	0.00199	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS1—malignant glioma	4.64e-05	0.00199	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CAT—malignant glioma	4.53e-05	0.00194	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—BCAN—malignant glioma	4.51e-05	0.00193	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTP1—malignant glioma	4.49e-05	0.00192	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.4e-05	0.00188	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CAT—malignant glioma	4.37e-05	0.00187	CbGpPWpGaD
Zoledronate—CA2—Metabolism—BCHE—malignant glioma	4.31e-05	0.00185	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NCOR1—malignant glioma	4.28e-05	0.00183	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC5A5—malignant glioma	4.26e-05	0.00182	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	4.19e-05	0.00179	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NCOR1—malignant glioma	4.12e-05	0.00177	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CAV1—malignant glioma	3.99e-05	0.00171	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HEY2—malignant glioma	3.82e-05	0.00164	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IDH1—malignant glioma	3.73e-05	0.0016	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—IDH2—malignant glioma	3.63e-05	0.00156	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CG—malignant glioma	3.63e-05	0.00156	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HEY1—malignant glioma	3.54e-05	0.00151	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARG—malignant glioma	3.51e-05	0.0015	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CAV1—malignant glioma	3.49e-05	0.00149	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CA—malignant glioma	3.47e-05	0.00149	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIST1H3B—malignant glioma	3.44e-05	0.00147	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTP1—malignant glioma	3.43e-05	0.00147	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.43e-05	0.00147	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2B6—malignant glioma	3.42e-05	0.00146	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CAV1—malignant glioma	3.36e-05	0.00144	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAT—malignant glioma	3.34e-05	0.00143	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.33e-05	0.00143	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CD—malignant glioma	3.19e-05	0.00137	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CG—malignant glioma	3.17e-05	0.00136	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NCOR1—malignant glioma	3.15e-05	0.00135	CbGpPWpGaD
Zoledronate—ABCC1—Disease—JAG2—malignant glioma	3.14e-05	0.00134	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—IDH1—malignant glioma	3.12e-05	0.00134	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARG—malignant glioma	3.06e-05	0.00131	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CG—malignant glioma	3.06e-05	0.00131	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SPHK1—malignant glioma	3.02e-05	0.00129	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2C18—malignant glioma	2.96e-05	0.00127	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARG—malignant glioma	2.95e-05	0.00126	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—malignant glioma	2.84e-05	0.00122	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.79e-05	0.0012	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CD—malignant glioma	2.79e-05	0.00119	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CB—malignant glioma	2.78e-05	0.00119	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—malignant glioma	2.76e-05	0.00118	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CD—malignant glioma	2.69e-05	0.00115	CbGpPWpGaD
Zoledronate—ABCC1—Disease—H3F3A—malignant glioma	2.65e-05	0.00114	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAV1—malignant glioma	2.57e-05	0.0011	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.54e-05	0.00109	CbGpPWpGaD
Zoledronate—ABCC1—Disease—JAG1—malignant glioma	2.5e-05	0.00107	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.46e-05	0.00105	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FBXW7—malignant glioma	2.45e-05	0.00105	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CB—malignant glioma	2.43e-05	0.00104	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—malignant glioma	2.41e-05	0.00103	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTEN—malignant glioma	2.4e-05	0.00103	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTT1—malignant glioma	2.4e-05	0.00103	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CB—malignant glioma	2.35e-05	0.001	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CG—malignant glioma	2.34e-05	0.001	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—malignant glioma	2.32e-05	0.000995	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARG—malignant glioma	2.26e-05	0.000967	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS1—malignant glioma	2.24e-05	0.000961	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.24e-05	0.000958	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTEN—malignant glioma	2.1e-05	0.0009	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—BCHE—malignant glioma	2.09e-05	0.000893	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC5A5—malignant glioma	2.06e-05	0.000883	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CD—malignant glioma	2.06e-05	0.000881	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTEN—malignant glioma	2.03e-05	0.000868	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.95e-05	0.000835	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.93e-05	0.000827	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN2B—malignant glioma	1.92e-05	0.000822	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.9e-05	0.000813	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HES1—malignant glioma	1.83e-05	0.000785	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NCOR1—malignant glioma	1.82e-05	0.00078	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CB—malignant glioma	1.79e-05	0.000768	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—malignant glioma	1.78e-05	0.000761	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PDGFRA—malignant glioma	1.74e-05	0.000747	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CA—malignant glioma	1.7e-05	0.000726	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.68e-05	0.000721	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTP1—malignant glioma	1.66e-05	0.000711	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAT—malignant glioma	1.62e-05	0.000692	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TERT—malignant glioma	1.61e-05	0.000687	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HLA-A—malignant glioma	1.61e-05	0.000687	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PDGFB—malignant glioma	1.57e-05	0.000671	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGFR1—malignant glioma	1.56e-05	0.000668	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTEN—malignant glioma	1.55e-05	0.000663	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIF1A—malignant glioma	1.54e-05	0.000657	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOR1—malignant glioma	1.53e-05	0.000653	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CAV1—malignant glioma	1.49e-05	0.000636	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CA—malignant glioma	1.48e-05	0.000635	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CA—malignant glioma	1.43e-05	0.000612	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BAD—malignant glioma	1.4e-05	0.000598	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—malignant glioma	1.39e-05	0.000593	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOTCH1—malignant glioma	1.38e-05	0.000592	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD80—malignant glioma	1.36e-05	0.00058	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APC—malignant glioma	1.35e-05	0.000579	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGF—malignant glioma	1.34e-05	0.000573	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTPN11—malignant glioma	1.33e-05	0.000569	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BRAF—malignant glioma	1.27e-05	0.000544	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAV1—malignant glioma	1.24e-05	0.000533	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT2—malignant glioma	1.24e-05	0.00053	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—malignant glioma	1.21e-05	0.000519	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CD—malignant glioma	1.19e-05	0.000509	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.19e-05	0.000509	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—malignant glioma	1.17e-05	0.0005	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF2—malignant glioma	1.14e-05	0.000488	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CG—malignant glioma	1.13e-05	0.000485	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARG—malignant glioma	1.09e-05	0.000468	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—malignant glioma	1.09e-05	0.000468	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MDM2—malignant glioma	1.07e-05	0.000456	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RAF1—malignant glioma	1.06e-05	0.000455	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB2—malignant glioma	1.05e-05	0.00045	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CB—malignant glioma	1.04e-05	0.000444	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—malignant glioma	1.03e-05	0.00044	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CD—malignant glioma	9.96e-06	0.000426	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTEN—malignant glioma	8.96e-06	0.000384	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—malignant glioma	8.93e-06	0.000382	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CB—malignant glioma	8.68e-06	0.000372	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—malignant glioma	8.6e-06	0.000368	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT3—malignant glioma	8.01e-06	0.000343	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTEN—malignant glioma	7.5e-06	0.000321	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—malignant glioma	7.44e-06	0.000319	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGFR—malignant glioma	7.28e-06	0.000312	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KRAS—malignant glioma	6.88e-06	0.000294	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—malignant glioma	6.32e-06	0.000271	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—malignant glioma	5.29e-06	0.000227	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—malignant glioma	5.16e-06	0.000221	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—malignant glioma	4.32e-06	0.000185	CbGpPWpGaD
